Abiopharma

🔍 Honaker Jeffrey Charles (Executive)

Company: Phoenix Education Partners, Inc. (PXED)

Report Date: 2026-04-21

Detailed Transactions and Holdings:

• Acquired 5,196 shares of Common Stock, par value $0.01 per share (Direct)
  Date: 2026-04-21 | Code: A | equity_swap_involved: 0 | shares_owned_after: 30,132.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Consists of restricted stock units granted under the Phoenix Education Partners, Inc. 2025 Omnibus Incentive Plan (the "Omnibus Incentive Plan") that will vest and become shares of the Issuer's common stock in accordance with the following: (i) 1/3 of such units shall vest on October 8, 2026, and (ii) the remaining 2/3 of such units shall vest in eight equal installments on each three-month anniversary thereafter over two years.